Global Herbal Supplements and Medicine Market Growth (Status and Outlook) 2024-2030

Global Herbal Supplements and Medicine Market Growth (Status and Outlook) 2024-2030

Herbal supplements are products derived from plants, including their oils, roots, leaves, seeds, berries or flowers.

The global Herbal Supplements and Medicine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Herbal Supplements and Medicine Industry Forecast” looks at past sales and reviews total world Herbal Supplements and Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Herbal Supplements and Medicine sales for 2023 through 2029. With Herbal Supplements and Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herbal Supplements and Medicine industry.

This Insight Report provides a comprehensive analysis of the global Herbal Supplements and Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Herbal Supplements and Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herbal Supplements and Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herbal Supplements and Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herbal Supplements and Medicine.

United States market for Herbal Supplements and Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Herbal Supplements and Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Herbal Supplements and Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Herbal Supplements and Medicine players cover Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Herbal Supplements and Medicine market by product type, application, key players and key regions and countries.

Segmentation by Type:
Prescription Drug
OTC

Segmentation by Application:
Cardiovascular
Tumor
Respiratory System
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Prescription Drug
OTC

Segmentation by Application:
Cardiovascular
Tumor
Respiratory System
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.